• Transient Bulk Transfection by Flow Electroporation

Related stories

Laboratory Products

Transient Bulk Transfection by Flow Electroporation

Oct 04 2010

CCS Cell Culture Service has established a new technology, which is now offered as a custom service to clients within drug discovery industries. By using the MaxCyte® STX™ Scalable Transfection System CCS is able to transfect batches of up to 10 billion cells in less than 30 minutes. Cell lines, primary cells and stem cells are reproducibly and efficiently transfected while maintaining the integrity of the cells for subsequent assays. As a result, bulk quantities of assay-ready frozen instant cells, which are transiently expressing targets of interest can now be rapidly prepared.

“We are very excited about this technology. Difficult targets or target complexes can now be easily addressed in a high-throughput screening scale by using large quantities of validated transiently transfected cells, even in more in vivo-like cellular backgrounds,” commented Dr Oliver Klotzsche, Managing Director of CCS.

“We are very pleased that CCS has decided to acquire the MaxCyte STX. By providing transient bulk transfection as a custom service, CCS enables everybody to benefit from our technology and helps to get it established as an important tool for drug discovery,” stated Douglas Doerfler, President and CEO at MaxCyte.

Related stories


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events